These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2868073)

  • 1. Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
    Candy JM; Gascoigne AD; Biggins JA; Smith AI; Perry RH; Perry EK; McDermott JR; Edwardson JA
    J Neurol Sci; 1985 Dec; 71(2-3):315-23. PubMed ID: 2868073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin-like immunoreactivity within neuritic plaques.
    Armstrong DM; LeRoy S; Shields D; Terry RD
    Brain Res; 1985 Jul; 338(1):71-9. PubMed ID: 2862952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread reduction of somatostatin-like immunoreactivity in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Svendsen CN; Bird ED; Martin JB
    Ann Neurol; 1986 Oct; 20(4):489-95. PubMed ID: 3789664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P; Katzman R; Terry RD
    Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type.
    Crystal HA; Davies P
    J Neurochem; 1982 Jun; 38(6):1781-4. PubMed ID: 6176686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
    Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical somatostatin, neuropeptide Y, and NADPH diaphorase neurons: normal anatomy and alterations in Alzheimer's disease.
    Kowall NW; Beal MF
    Ann Neurol; 1988 Feb; 23(2):105-14. PubMed ID: 2897822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of somatostatin and neuropeptide Y distribution in monkey brain.
    Beal MF; Mazurek MF; Martin JB
    Brain Res; 1987 Mar; 405(2):213-9. PubMed ID: 3567602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subpopulations of somatostatin 28-immunoreactive neurons display different vulnerability in senile dementia of the Alzheimer type.
    Gaspar P; Duyckaerts C; Febvret A; Benoit R; Beck B; Berger B
    Brain Res; 1989 Jun; 490(1):1-13. PubMed ID: 2569349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.
    Rossor MN; Emson PC; Mountjoy CQ; Roth M; Iversen LL
    Neurosci Lett; 1980 Dec; 20(3):373-7. PubMed ID: 6108540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease.
    Beal MF; Mazurek MF; Tran VT; Chattha G; Bird ED; Martin JB
    Science; 1985 Jul; 229(4710):289-91. PubMed ID: 2861661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin-28(1-12)-like immunoreactivity is reduced in Alzheimer's disease cerebral cortex.
    Beal MF; Benoit R; Mazurek MF; Bird ED; Martin JB
    Brain Res; 1986 Mar; 368(2):380-3. PubMed ID: 2870772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications.
    Papasozomenos SC
    Lab Invest; 1989 Jan; 60(1):123-37. PubMed ID: 2492060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galanin-like immunoreactivity is present in human substantia innominata and in senile plaques in Alzheimer's disease.
    Kowall NW; Beal MF
    Neurosci Lett; 1989 Mar; 98(1):118-23. PubMed ID: 2469045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer dementia and reduced nicotinamide adenine dinucleotide (NADH)-diaphorase activity in senile plaques and the basal forebrain.
    Jacobs RW; Farivar N; Butcher LL
    Neurosci Lett; 1985 Jan; 53(1):39-44. PubMed ID: 3838807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin- and neuropeptide Y-immunoreactive neurons in the neocortex in senile dementia of Alzheimer's type.
    Nakamura S; Vincent SR
    Brain Res; 1986 Apr; 370(1):11-20. PubMed ID: 2871890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Catecholaminergic systems in the amygdaloid complex of SDAT and aged controls: tyrosine hydroxylase immunohistochemistry].
    Nakamura S; Kawamata T; Akiguchi I; Kameyama M; Kimura H
    Rinsho Shinkeigaku; 1989 Mar; 29(3):296-300. PubMed ID: 2568896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galanin-like immunoreactivity is unchanged in Alzheimer's disease and Parkinson's disease dementia cerebral cortex.
    Beal MF; Clevens RA; Chattha GK; MacGarvey UM; Mazurek MF; Gabriel SM
    J Neurochem; 1988 Dec; 51(6):1935-41. PubMed ID: 2460590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corticotropin-releasing factor-like immunoreactivity in senile dementia of the Alzheimer type. Reduced cortical and striatal concentrations.
    Bissette G; Reynolds GP; Kilts CD; Widerlöv E; Nemeroff CB
    JAMA; 1985 Dec; 254(21):3067-9. PubMed ID: 3877182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholecystokinin and somatostatin in Alzheimer's disease postmortem cerebral cortex.
    Mazurek MF; Beal MF
    Neurology; 1991 May; 41(5):716-9. PubMed ID: 1674117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.